GNW - GENWORTH FINANCIAL INC

Preliminary

A preliminary proxy filing has been made. Full AI analysis will be available once definitive filings are filed.

This is a preliminary filing stage. A PREC14A has been filed but no definitive proxy (DEFC14A) has been submitted yet. This summary is factual only — no voting recommendation is provided at this stage.

What This Filing Is

This is a preliminary proxy statement (PREC14A) filed by Genworth Financial, Inc.'s management and Board of Directors in connection with the company's 2026 Annual Meeting of Stockholders. Management is soliciting proxies in support of its own director nominees and proposals, with no dissident or activist challenger involved.

Background

Genworth Financial, Inc. (GNW) is an insurance holding company whose primary business segments include Enact Holdings, Inc. (a majority-owned (~81%) private mortgage insurance subsidiary), a legacy "Closed Block" of long-term care, life, and annuity insurance products, and a growing new business called CareScout (aging care services and insurance). The company has been executing a multi-year rate action plan (MYRAP) on its legacy LTC insurance in-force since 2012 and has been returning capital to shareholders through share repurchases since May 2022. The company also disclosed a non-material correction of a reinsurance recoverable accounting error in Q4 2025 and conducted a related clawback analysis finding no erroneously awarded compensation.

What the Filer Is Demanding

This is a management-filed proxy; the Board is asking shareholders to vote FOR the following proposals:

Proposal 1: Election of ten director nominees to serve until the 2027 Annual Meeting
Proposal 2: Advisory (non-binding) approval of named executive officer (NEO) compensation ("say-on-pay")
Proposal 3: Approval of the 2026 Genworth Financial, Inc. Associate Stock Purchase Plan (ASPP), which would authorize up to 6,000,000 shares (~1.6% of shares outstanding)
Proposal 4: Ratification of KPMG LLP as independent registered public accounting firm for 2026

Key Arguments Made

Strategic and Financial Performance:

Enact generated $558 million in adjusted operating income in 2025, with a PMIERs sufficiency ratio of 162% ($1.9 billion above requirements); Genworth received $407 million of Enact's free cash flows through its ~81% ownership stake
Enact paid $98 million in quarterly dividends to Genworth in 2025; Genworth also received $309 million through Enact share repurchases
Genworth repurchased $245 million of its own common stock in 2025 at an average price of $7.99 per share; a new $350 million repurchase authorization was announced in September 2025
Holding company debt reduced to $783 million as of December 31, 2025; debt-to-capital ratio (excluding Closed Block) maintained below 25%
MYRAP has delivered an estimated $34.5 billion in net present value since 2012, representing approximately 87% completion

CareScout Growth Initiatives:

CareScout Quality Network expanded to over 1,000 home care locations nationwide with 95%+ coverage of the U.S. population aged 65+
Launched "Care Assurance," CareScout's inaugural long-term care insurance product, live in 39–40 states as of filing
Acquired Seniorly (a senior living navigation platform) in October 2025 to accelerate direct-to-consumer expansion
CareScout Services exceeded its 2025 customer network match target of 2,500, achieving 3,255 matches

Executive Compensation:

CEO Thomas J. McInerney received total 2025 compensation of $10,077,378, with 89% of target pay linked to company performance
Annual incentive funding was above target for most NEOs (CEO: 142% of target; CFO: 142%; CIO: 165%; CareScout CEO: 161%); U.S. Life Insurance CEO was at 125%
2023–2025 PSU awards paid out at 85% of target (below target), driven primarily by U.S. Life Insurance statutory net income falling below threshold; Enact Adjusted Operating Income achieved 200% and TSR achieved 150%
CEO-to-median-employee pay ratio was 95:1 (median associate total compensation: $106,253)
Supplemental Discretionary Clawback Policy was expanded in 2025 to explicitly include time-based equity awards, in response to shareholder feedback
Approximately 90% of shares voted at the 2025 Annual Meeting were cast in favor of the say-on-pay proposal

Corporate Governance:

9 of 10 director nominees are independent under NYSE standards
Board established a Technology Committee in 2025 (converted to a permanent standing committee in February 2026), chaired by newly added director Steven C. Van Wyk (technology/CIO background)
Majority voting for directors in uncontested elections; annual director elections; no poison pill; stockholder ability to call special meetings
Shareholder outreach covered approximately 60% of shares outstanding during 2025
A stockholder submitted four proposals via Bylaws advance notice procedures in February 2026; the Board determined the submission did not comply with Bylaws requirements and none will be presented at the meeting

Accounting Correction:

A non-material error in measurement of reinsurance recoverable for traditional life insurance products was corrected in Q4 2025, reducing equity as of December 31, 2022 by $50 million after-tax and increasing 2025 net income by $11 million
A clawback analysis concluded no executive compensation was erroneously awarded as a result of the correction

Meeting Date

Wednesday, May 20, 2026, at 9:00 a.m. ET (virtual meeting at www.virtualshareholdermeeting.com/GNW2026)

Activist Identity

Management filing. This proxy was filed by Genworth Financial, Inc.'s Board of Directors and management. There is no activist investor or dissident slate involved in this filing.

Status

This is a preliminary proxy statement subject to completion, dated March 24, 2026. No definitive proxy has been filed yet. The filing is at an early stage and the proxy materials are expected to be distributed to shareholders on or about April [date to be specified], 2026.